| CAS NO: | 477202-00-9 |
| 规格: | ≥98% |
| 包装 | 价格(元) |
| 10mg | 电议 |
| 25mg | 电议 |
| 50mg | 电议 |
| 100mg | 电议 |
| 250mg | 电议 |
| In vitro | Ipilimumab inhibits CTLA-4, allowing the T cell immune response to be reactivated against tumor cells. Ipilimumab can promote antitumor activity as a single agent or in combination with cytokines, chemotherapy, or vaccines. |
|---|---|
| In Vivo | N/A |
| Protocol | |
| References | Expert Opin Biol Ther. 2009 Feb;9(2):231-41. |
m.cnreagent.com